Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference28 articles.
1. Global tuberculosis report 2017,2017
2. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study;Borisov;Eur Respir J,2017
3. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update;Falzon;Eur Respir J.,2017
4. Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases;Caminero;Eur Respir J,2017
5. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence;Pontali;Eur Respir J,2016
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. State of the Art in Nanomedicine;Nanomedicine;2024-07-26
2. Bedaquiline and delamanid treatment outcomes among patients with drug-resistant tuberculosis: a systematic review and meta-analysis;Minerva Respiratory Medicine;2024-03
3. Bedaquiline’s Safety Profile Monitoring in India: Considerations for Future - A Systematic Review;Current Drug Safety;2024-02
4. Designing molecular diagnostics for current tuberculosis drug regimens;Emerging Microbes & Infections;2023-02-27
5. Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure;eClinicalMedicine;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3